{"retracted":false,"update":{"timestamp":1487116800000,"doi":"10.1080/09546634.2016.1245484","type":"correction"},"doi":"10.1080/09546634.2016.1214671","journal":"Journal of Dermatological Treatment","publisher":"Informa UK Limited","title":"Correction to: Early clinical response to tofacitinib treatment as a predictor of subsequent efficacy: Results from two phase 3 studies of patients with moderate-to-severe plaque psoriasis"}
